STATIC Ibrutinib trial (FLAIR follow on) updat... - CLL Support

CLL Support

22,776 members39,090 posts

STATIC Ibrutinib trial (FLAIR follow on) update for UK members

Jm954 profile image
Jm954Administrator
5 Replies

The STATIC team have released an update which is on the CLL Support website.

In brief, there will be no patient choice arm so patients cannot elect to continue Ibrutinib.

"We have made some changes in the STATIC trial design due to a variety of reasons, including feedback from the funders of STATIC, the National Institute of Health Research Healthcare Technology Assessment Programme, but also with the emergence of the initial results from the FLAIR trial and other trials indicating the continuing risk of increasing toxicity with prolonged time on ibrutinib and that some patients stopping ibrutinib for toxicity have prolonged periods before needing further treatment.

The principle modification in STATIC is that the patient choice group was felt to be inappropriate, particularly as any patient randomised to the intermittent treatment arm of STATIC would go back on ibrutinib at the first sign of their CLL returning. This modification was done with input from the UK CLL patient organisations as well as UK CLL experts.

We want to reassure everyone wanting to take part in STATIC when they finish 6 years of ibrutinib treatment in FLAIR that STATIC includes a “randomisation trial” and “clinical need group”. The trial is designed in such a way that the participants who would not be considered appropriate for the randomisation trial, for example if their blood count is not at acceptable levels, could receive the drug in the “clinical need group”.

The “randomisation trial” will be only recruiting participants who are in clinical remission as defined by the trial protocol. All participants from FLAIR trial who have already finished six years of ibrutinib will be able to participate in the trial, if they choose, with the same criteria as those patients from FLAIR still on treatment."

More details here:

images.cllsupport.org.uk/ht...

Jackie

Written by
Jm954 profile image
Jm954
Administrator
To view profiles and participate in discussions please or .
Read more about...
5 Replies
fapumpkin profile image
fapumpkin

Thank you so much for the much needed update.

annmcgowan profile image
annmcgowan

Thanks Jackie. Many of us have been keen to get more information on Static.

Ann

SycamoreN profile image
SycamoreN

Can patients who have not been on the FLAIR trial enter the STATIC trial?

Jm954 profile image
Jm954Administrator in reply to SycamoreN

Yes

zaax profile image
zaax

That quite reassuring, though worrying that some people are having toxicity problems being on Ibrutinib long term (5 years for me)

You may also like...

Follow up to static dilemma

dilemma over whether I should move from the flair trial to the static trial. I saw my...

6 years on Ibrutinib Should I join STATIC trial

Should I join STATIC trial after being on Ibrutinib for almost 6 years. I did talk to my consultant

FLAIR Trial 2018 update

This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia...

Static trial dilemma

to complete the Flair Trial, having completed 6 years on the ibrutinib and rituximab arm in March...

End of FLAIR. No more Ibrutinib. Great improvement!

antibody targetting CLL cells, suitable for patients who have responded to treatment but would not...